Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Abstract Background Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have reported, through in vitro and in vivo research involving pancreatic ca...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2020-07-01
Sarja:BMC Cancer
Aiheet:
Pancreatic cancer
Iron chelation
Cancer therapy
Rho family protein
Deferasirox
Invasion
Linkit:http://link.springer.com/article/10.1186/s12885-020-07167-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia